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Highlights 
 Porcine circovirus type 2 (PCV2) is an important pig virus. 
 PCV2 vaccination is widely used. 
 PCV2d-2 is the main PCV2 genotype in US samples. 
 Abstract 
Porcine circovirus type 2 (PCV2) vaccination was introduced in the US in 2006 and 
since has been adopted by most pig producers. While porcine circovirus associated 
disease (PCVAD) outbreaks are now relatively uncommon in the US, PCV2 remains a 
concern which is emphasized by increasing numbers of PCR and sequencing requests 
for PCV2. In the present study, randomly selected lung tissues from 586 pigs 
submitted in 2015 were tested for presence of PCV2 DNA. Positive samples were 
further characterized by sequencing and combined with available PCV2 
open-reading-frame (ORF) 2 sequences from the client data base of the Iowa State 
University Veterinary Diagnostic Laboratory. The prevalence of PCV2 in the 
randomly selected lung tissues was 23% (135/586) with 11.3% PCV2a, 29% PCV2b 
and 71.8% for PCV2d subgroup PCV2d-2. A total of 455 ORF2 sequences obtained 
from 2014 through 2016 were analyzed and PCV2d accounted for 66.7% of the 2014 
sequences, 71.8% of the 2015 sequences, and 72% of the 2016 sequences. 
Interestingly, only 1.9% (9/455) of the sequences belonged to the recently identified 
PCV2e genotype. The present data indicates that despite an almost 100% PCV2 
vaccine coverage in the US, PCV2 DNA can still be detected in almost 1 of 4 
randomly selected pig tissues. PCV2d-2 is now the predominant genotype in the USA 
suggesting that PCV2d-2 may have some advantage over PCV2a and PCV2b in its 
ability to replicate in pigs under vaccination pressure. 
 
1. Introduction 
Porcine circovirus (PCV) type 2 is considered to be among the most important 
pathogens in the global swine industry (Allan et al., 2012; Meng, 2012; Segalés, 
2015). PCV2 was identified in 1998 in pigs from Canada with postweaning 
multisystemic wasting syndrome (PMWS) (Ellis et al., 1998; Segalés et al., 2005). At 
least five PCV2 genotypes including PCV2a, PCV2b, PCV2c, PCV2d and the 
recently identified PCV2e have been recognized or are proposed to date (Davies et al., 
2016; Franzo et al., 2015b; Xiao et al., 2015).  
The first identified PCV2 genotype, PCV2a, is also the oldest genotype and 
most currently available commercial PCV2 vaccines are based on this virus cluster. 
PCV2a predominated in the global pig herds until around 2003 when a global 
genotype shift from PCV2a to PCV2b was observed (Beach and Meng, 2012). This 
genotype shift from PCV2a towards PCV2b was often associated with apparent 
increased severity of clinical disease and high morbidity and mortality in pig herds 
located in regions where PCV2b was introduced (Beach and Meng, 2012; Patterson 
and Opriessnig, 2010). Since its appearance in North America in 2005, PCV2b has 
been the predominant strain in the US pig population.  
PCV2c was discovered in archived swine serum samples in Denmark (Dupont 
et al., 2008) and recently was also detected in a feral pig in Brazil (Franzo et al., 
2015a) but is likely of minor importance. PCV2d can be classified into PCV2d-1 and 
PCV2d-2, with substantial genetic divergence between them (Xiao et al., 2015). 
PCV2d-1 strains were first identified in 2002 in China (Cortey et al., 2011; Wang et 
al., 2009) while PCV2d-2 strains were first recognized in 2008 in China and have 
been linked with increased virulence (Guo et al., 2010, 2012; Xiao et al., 2015). In 
2012, PCV2d-2 was also identified in US pigs in cases of apparent vaccine failure 
(Xiao et al., 2012, 2015). Subsequently, PCV2d-2 has also been detected in South 
America, Europe and Asia (Segalés, 2015; Xiao et al., 2015).  
In 2015, four new and distinct PCV2 sequences were identified in pig samples 
from Mexico and the US (Harmon et al., 2015). Ten similar PCV2 sequences were 
also identified in the US in a recent retrospective analysis with the earliest sequence 
dating back to 2006 (Davies et al., 2016). The open-reading-frame (ORF) 2 of these 
PCV2 isolates is 717 bp in length, 15 bp longer than that of PCV2a or PCV2b isolates 
and 12 bp longer than that of PCV2c and PCV2d, and shows only about 85% identity 
to other known PCV2 ORF2 sequences (Davies et al., 2016; Harmon et al., 2015). 
Due to the substantial genomic differences of the ORF2 composition of this group of 
PCV2 isolates, a new PCV2 genotype, PCV2e, has been proposed (Davies et al., 
2016). Little is known to date on distribution, prevalence rates and importance of 
PCV2e isolates.  
The objectives of this study were to investigate the prevalence of PCV2 DNA 
in a set of 586 randomly selected 2015 diagnostic pig lung submissions and to 
determine the distribution of PCV2 genotypes in US pigs prior to April 2016.  
 
2. Material and methods 
2.1. Tissue sample source and origin, processing and DNA extraction 
2.1.1. Sample source and origin. A total of 586 lung tissues were randomly 
selected from routine diagnostic cases submitted from January through March 2015 to 
the Iowa State University Veterinary Diagnostic Laboratory (ISU-VDL). The lung 
samples originated from 22 U.S. states (Table 1) and pig age ranged from 2 days to 
adults. Overall there were 79/586 suckling pigs (up to 3 weeks of age), 163/586 
nursery pigs (3-8 weeks of age), 200/586 grow finish pigs (8-25 weeks of age) and 
15/586 adult pigs. The age of 129/586 pigs was not given on the submission form. 
The clinical history of the pigs included no clinical signs (n=2), abortion (n=8), 
central nervous signs (n=14), respiratory signs (n=315), enteric signs (n=46), mixed 
respiratory and enteric signs (n=61), systemic disease (n=16), or poor body condition 
(n=1). No clinical history was given for the remaining 123 cases.  
2.1.2. Sample processing. Approximately one gram of lung tissue was minced 
by scissors, diluted 1:10 in Dulbecco’s Modified Eagle Medium (DMEM), 
homogenized by using a Stomacher 80 (Seward Laboratory Systems Inc, Bohemia, 
NY, USA), and centrifuged at 1500 g for 10 min to obtain the supernatant. All 
samples were stored at -80
o
C. 
2.1.3 Viral DNA extraction. DNA was extracted from 50 µl of each tissue 
homogenate using the 5×MagMAX
TM
 96 Viral Isolation Kit (Ambion) according to 
the manufacturers’ instructions on an automated extraction platform (KingFisher Flex; 
Thermo Fisher Scientific Inc.). DNA was eluted in 50 µl of elution buffer provided in 
the kit. All DNA extraction procedures included a positive control and a negative 
control (water) in each run. 
2.2. Real-time PCV2 PCR assays  
To demonstrate PCV2 DNA in a sample, a Taqman® real-time PCR assay 
which targets the conserved ORF1 gene of PCV2 and is capable to detect all known 
PCV2 genotypes including the newly identified PCV2e, without differentiation, was 
performed as described (Opriessnig et al., 2013). Samples that were ORF1 PCV2 
DNA positive were further tested by a multiplex Taqman® real-time PCR which 
targets the signature motif region within the capsid gene (ORF2) and detects and 
differentiates PCV2a, PCV2b and PCV2d as described (Opriessnig et al., 2013).To 
detect the novel PCV2e, a PCV2e specific Taqman® real-time PCR targeting ORF2 
was developed which used the following primers PCV2eF: 
5-CTCTCCCGCTCCTTTGTATATACTG-3 and PCV2eR: 
5-TCCAATATTAAATCTCATCATGTCCAC-3 and the PCV2e probe: CAL Fluor® 
Orange 560-5’-TAACCTCCACAGTCACACCGCCATCAT-3-BHQ-1. The PCR 
reactions were carried out in 96-well plates. Each reaction consisted of a total volume 
of 25 μl, containing 12.5 μl of TaqMan Universal PCR Master Mix (Applied 
Biosystems, Foster City, California, USA), 2.5 μl of sample or standard DNA, 1 μl of 
10 μm of each of the two primers, 0.5 μl of 10 μm probe, and 7.5 μl distilled water. 
Amplification was performed using the ABI7500 Fast Real Time PCR System 
(Applied Biosystems, Foster City, California, USA) under universal conditions: 2 min 
at 50°C 10 min at 95 °C, 40 cycles of 15 s at 95 °C and 1 min at 60 °C. 
2.3. PCV2 ORF2 sequencing  
To obtain PCV2 ORF2 sequences, all ORF1 PCV2 PCR positive samples 
were re-amplified by primers covering the ORF2 gene and were sequenced as 
described (Opriessnig et al., 2013).  
2.4. External obtained PCV2 ORF2 sequences  
A total of 372 ORF2 sequences were obtained through the ISU-VDL LIMS 
data base which corresponded to client case requests, spanned the time frame from 
January 2014 through April 2016, and included sequences obtained from pigs located 
in 16 U.S. states (Table 2). 
2.5. Sequence alignment and analysis 
The sequences were aligned and analyzed with software ClustalW and 
MEGA5.0 as described (Xiao et al., 2015). The obtained sequences from the tissue set 
were combined with the ISU-VDL sequences and analyzed. 
2.6. Nucleotide sequence GenBank accession numbers 
The 455 ORF2 sequences of PCV2 analyzed in the present study have been 
deposited into GenBank under the accession numbers KU697001-KU697292, 
KT795288-KT795290, KX098659-KX098782 and KX510050-KX510085. 
 
3. Results  
3.1. PCV2 prevalence in randomly selected 2015 lung samples in the USA 
Of the 586 lung samples, PCV2 DNA was identified in 23% (135/586) by 
PCV2 ORF1 real-time PCR. When the samples were categorized by Ct value 3.9% of 
the samples (23/586) contained high amounts of PCV2 DNA (Ct values < 20.1), 3.6% 
(21/586) contained medium amounts of PCV2 DNA (Ct values from 20.1 to 25.0), 
9.2%% (54/586) contained low amounts of PCV2 DNA (Ct values from 25.1-35.0), 
6.3% (37/586) contained insignificant amounts of PCV2 DNA (Ct values from 
35.1-40.0) and 77% of the cases (451/586) were negative for PCV2 DNA.  
3.2. PCV2 genotypes identified in random lung tissues 
Among the 135 ORF1 PCV2 DNA positive samples, 124 were further 
successfully genotyped by the PCV2 ORF2 differential real-time PCR assay. 
Specifically, PCV2a was detected in 11.3% of the samples (14/124), PCV2b was 
detected in 29% of the samples (36/124) and PCV2d was detected in 71.8% of the 
samples (89/124) (Table 1). Among all 124 samples, 15 samples were co-infected 
with two different PCV2 genotypes (Table 1).  
3.3. Analysis of PCV2 ORF2 sequences  
The ORF2 gene of 83 of the 135 PCV2 ORF2 positive samples was 
successfully sequenced, and 12% (10/83) of the sequences corresponded to PCV2a, 
20.5% (17/83) were PCV2b, and 67.5% (56/83) were PCV2d which was in agreement 
with the multiplex real-time PCR results. PCV2c or PCV2e sequences were not 
obtained in the samples set. This was further confirmed by a differential real-time 
PCR assay specific for PCV2e which was negative on all samples.  
The genotype distribution of PCV2 genotypes from 2011 through April 2016 
based on 598 ORF2 sequences is listed in Table 3. Among the 455 ORF2 sequences 
obtained in this study (372 external ISU-VDL LIMS sequences and 83 sequences 
from random lung tissues), 143 previously published ORF2 sequences (Xiao et al., 
2015) have also been added for completeness. PCV2c was not detected in the US in 
the present investigation. Further phylogenetic analysis of the ORF2 sequences 
together with reference sequences confirmed the presence of five distinct PCV2 
genotypes, and all of the present PCV2d sequences are clustered in the PCV2d-2 
clade (Fig. 1). The p-distance of the ORF2 nucleotide sequences of PCV2e with other 
PCV2 genotypes ranges from 0.15 to 0.17, which is much larger than the PCV2 
genotype-definition threshold of 0.035. When the amino acid sequences in the ORF2 
gene of the five main PCV2 genotypes were aligned (Fig. 2), PCV2d had four unique 
amino acid changes and 3 of the 4 amino acids were located in an immunoreactive 
region. PCV2e had 24 amino acids not present in any of the other genotypes and 12 of 
these 24 amino acids were located in immunoreactive regions (Fig. 2).  
 
4. Discussion 
Retrospective analysis of sequences available through GenBank indicate that 
PCV2d appeared in 1999 and can be divided into two main groups, PCV2d-1 and 
PCV2d-2 which contains emerging isolates (Xiao et al., 2015). PCV2d-2 was first 
recognized in April 2012 in the US (Xiao et al., 2012, 2015). The present data 
indicate that the prevalence of PCV2d-2 increased from 37.8% in 2012 to 72% in 
2016 suggesting that PCV2d-2 has replaced PCV2b and has now become the 
predominant PCV2 genotype in the USA.  
Most of the present samples or cases were from PCV2 vaccinated farms. The 
majority of the randomly selected lung samples used in this study was obtained from 
nursery to grow-finish pigs and overall 64.2% had a clinical history of respiratory 
signs. The great majority of these pigs had been vaccinated with commercial PCV2 
vaccines administered at the time weaning as is commonly done in US pig production; 
however, PCV2 DNA was found in 23% of the investigated cases, with moderate to 
high amounts in 32.6% (44/135) and with PCV2d-2 identified in 71.8%. This 
highlights that PCV2d-2 may have some advantage over PCV2a and PCV2b in its 
ability to replicate in pigs under vaccination pressure.  
Among the 44 field cases with moderate to high amounts of PCV2 DNA in the 
lungs, only 47.7% (22/44) were detected as PCV2 positive by either PCR or PCV2 
immunohistochemistry (IHC) tests during the case investigation. PCV2 testing was 
not requested or done on 41% of these cases (18/44). This suggests that a number of 
PCVAD cases could remain undiagnosed. In contrast, routine VDL PCR and IHC 
tests were done on 30.5% of negative or subclinical cases.  
The time of origin of PCV2 and the main PCV2 genotypes has been estimated. 
PCV2 was proposed to originate at the beginning of 20
th
 century (Firth et al., 2009) or 
between the middle of the 19th and the first half of the 20th century (Franzo et al., 
2016). In previous studies, PCV2a was undoubtedly revealed to be the oldest 
genotype, with the time to most recent common ancestor (TMRCA) estimated to be 
1966 (1945-1983) (Firth et al., 2009) or 1964 (1948-1974) (Franzo et al., 2016). The 
first PCV2 identified in a pig with PCVAD in 1962 was also PCV2a (Jacobsen et al., 
2009). For the TMRCA of PCV2b, there is a minor uncertainty as the PCV2b 
TMRCA has been estimated to be 1989 (1980–1995) (Firth et al., 2009) or 1973 
(1952–1996) (Franzo et al., 2016).The earliest PCV2b strain was identified in a PCV2 
IHC negative pig in 1979 from Switzerland (Wiederkehr et al., 2009). For PCV2d, the 
TMRCA was estimated to be 1986 (1971-1996) based on full genome analysis, which 
is similar to PCV2b, indicating PCV2d and PCV2b may have bifurcated early and 
evolved independently (Xiao et al., 2015). However, in a recent study the TMRCA of 
PCV2d was reported to be much earlier and already in 1958 (1935–1979), even earlier 
than PCV2b, indicating that PCV2d is older than PCV2b (Franzo et al., 2016). The 
disagreement in TMRCA for PCV2d has been proposed to result from utilizing 
different numbers of PCV2d strains for the analysis (Franzo et al., 2016). Up to now, 
the earliest identified PCV2d sequence in GenBank originated from a pig sample 
collected in 1999 in Switzerland (Xiao et al., 2015) and no PCV2d sequence has been 
identified earlier than PCV2b. The conclusion that PCV2d is indeed older than 
PCV2b is perhaps not sufficiently supported and additional investigations may be 
needed. 
The recent identification of a new PCV2e genotype further supports 
continuous evolution of PCV2. PCV2e has been present in the US since at least 2006 
as determined by a retrospective US investigation (Davies et al., 2016). Interestingly, 
in this study, from 2013-2016 only nine PCV2e sequences were obtained through 
submissions and client requests to the ISU-VDL, and no additional PCV2e sequences 
were identified in the GenBank database during a recent study (Xiao et al., 2015). The 
obtained PCV2e isolates originated in Iowa (n=7, 2015-2016), Indiana (n=1, 2015) 
and North Carolina (n=1, 2015). Given that PCV2e has been circulating in the US pig 
population for at least 10 years its rather low prevalence may indicate that PCV2e is 
replicating at a low level and perhaps PCV2e also has a lower transmission rate 
compared to other PCV2 genotypes. 
Further studies are needed to investigate the reasons for the emergence of 
PCV2d-2 and the importance (if any) of PCV2e. In the US, a genotype shift of 4 years 
duration from PCV2b to PCV2d-2 appears to have occurred. It is still unclear where 
the US PCV2d-2 strain originated from and if it truly only entered the US pig 
population around 2012.   
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Figure legends 
 
Fig. 1. The molecular phylogenetic analysis by Neighbor-Joining method. The 
analysis was based on the present 455 PCV2 complete ORF2 sequences together with 
19 reference sequences from GenBank. The evolutionary distances were computed 
using the p-distance method. All positions containing gaps and missing data were 
eliminated, and there were a total of 575 positions in the final dataset. The PCV1 
sequence were used as an outgroup to root the tree. The analyses were conducted in 
MEGA6. 
 
Fig. 2. Alignment of representative PCV2a, PCV2b, PCV2c, PCV2d and PCV2e 
ORF2 amino acid sequence. The grey areas correspond to antibody recognition 
domains described previously (Trible and Rowland, 2012). The dashed line box 
shows the location of an immunodominant decoy epitope within the epitope C domain 
(Trible and Rowland, 2012). Yellow highlighted amino acids are PCV2d specific and 
green highlighted amino acids are PCV2e specific. “-” represents the same residue as 
in the top sequence and “.” indicates an insertion or a deletion.  
Tables 
 
Table 1 Sample origin, number of PCV2 positive samples and PCV2 genotypes 
identified in 586 lung tissue samples obtained from January to March 2015 in the 
USA. 
State Number of 
tissues 
PCV2
1
 
PCV2 genotype
2
 
2a 2b 2d 2e 2a+2b 2b+2d 2a+2d Total 
IA 184 46 5 7 27 0 1 4 1 45 
NC 73 18 0 2 13 0 0 0 0 15 
IL 43 12 1 0 8 0 0 0 0 9 
IN 31 3 0 0 2 0 0 0 0 2 
MO 21 7 0 0 6 0 1 0 0 7 
MN 15 7 0 2 2 0 1 2 0 7 
UT 15 6 0 4 2 0 0 0 0 6 
NE 13 5 0 3 1 0 0 1 0 5 
ND 8 2 0 0 2 0 0 0 0 2 
KS 7 1 0 1 0 0 0 0 0 1 
CA 6 0 0 0 0 0 0 0 0 0 
OK 5 1 0 0 1 0 0 0 0 1 
PA 5 1 0 0 0 0 0 0 0 0 
VA 6 0 0 0 0 0 0 0 0 0 
CO 4 1 0 0 0 0 0 0 0 0 
SD 4 0 0 0 0 0 0 0 0 0 
AR 3 0 0 0 0 0 0 0 0 0 
OH 3 1 0 0 0 0 0 1 0 1 
GA 2 2 0 0 2 0 0 0 0 2 
SC 2 0 0 0 0 0 0 0 0 0 
VT 1 0 0 0 0 0 0 0 0 0 
WI 1 1 0 1 0 0 0 0 0 1 
Unknown  134 21 4 2 11 0 0 3 0 20 
Total 586 135 10 22 77 0 3 11 1 124 
1
Presence of PCV2 DNA was determined by real-time PCR targeting the conserved 
ORF1 gene (Opriessnig et al., 2013). 
2
Presence and differentiation of PCV2a, PCV2b or PCV2d were determined by 
differential real-time PCR targeting the ORF2 gene (Opriessnig et al., 2013) and 
presence of PCV2e was determined by using a PCV2e specific assay developed in 
this study.  
 
 Table 2 Sample origin, number of sequences per state and the PCV2 genotypes 
identified in 372 ORF2 sequences obtained through the Iowa State University 
Veterinary Diagnostic Laboratory LIMS system from January 2014 to April 2016. 
State Numbers of 
sequences included 
PCV2 genotype 
PCV2a PCV2b PCV2d PCV2e 
IA 81 19 4 51 7 
NC 136 1 11 123 1 
MD 17 9 0 8 0 
IN 36 7 3 25 1 
IL 32 4 2 26 0 
MO 11 4 0 7 0 
OH 4 0 1 3 0 
NE 3 1 2 0 0 
WI 3 1 0 2 0 
SC 1 0 1 0 0 
OK 2 1 0 1 0 
MN 6 5 0 1 0 
TX 2 1 1 0 0 
SD 1 0 0 1 0 
KY 1 1 0 0 0 
AR 1 0 0 1 0 
Unknown  35 10 6 19 0 
Total 372 64 (17.2%) 31 (8.3%) 268 (72%) 9 (2.4%) 
 
 
 Table 3 The genotype distribution of PCV2 ORF2 sequences obtained since initial 
discovery of PCV2d-2 in the US in 2012 through April 2016, including 372 ORF2 
sequences obtained through the ISU-VDL LIMS data base and 83 sequences obtained 
from 2015 lung tissue samples. 
 PCV2a PCV2b PCV2d-2 PCV2e Total 
2011* 4 (50%) 4 (50%) 0 0 8 
2012* 3 (8.1%) 20 (54.1%) 14 (37.8%) 0 37 
2013* 11 (11.2%) 51 (53.1%) 36 (36.7%) 0 98 
2014 8 (14%) 11 (19.3) 38 (66.7%) 0 57 
2015 55 (17.4%) 31 (9.8%) 227 (71.8%) 3 (0.9%) 316 
2016 (until April) 11 (13.4%) 6 (7.3%) 59 (72%) 6 (7.3%) 82 
Total 92 (15.4%) 123 (20.6%) 374 (62.5%) 9 (1.5%) 598 
*Data from Xiao et al. 2015. 
 
 


